PPA
PAVM icon

Parametric Portfolio Associates’s PAVmed PAVM Stock Holding History

Parametric Portfolio Associates’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$47K Sell
80
-115
-59% -$85.5K ﹤0.01% 3637
2021
Q4 		$216K Sell
195
-728
-79% -$1.58M ﹤0.01% 3397
2021
Q3 		$3.55M Buy
923
+109
+13% +$344K ﹤0.01% 2076
2021
Q2 		$2.35M Buy
814
+714
+714% +$1.69M ﹤0.01% 2345
2021
Q1 		$200K Buy
100
+28
+39% +$42.1K ﹤0.01% 3876
2020
Q4 		$68K Sell
72
-18
-20% -$15.4K ﹤0.01% 3921
2020
Q3 		$72K Sell
90
-2
-2% -$1.78K ﹤0.01% 3839
2020
Q2 		$88K Buy
+92
New +$92K ﹤0.01% 3805

Other funds holding PAVM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's PAVM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its PAVmed (PAVM) stake by 59% in Q1 2022, selling an estimated $85.5K and leaving 80 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

Parametric Portfolio Associates first reported a position in PAVM in Q2 2020 and has held it in 8 quarters since. The position peaked at $3.55M in Q3 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • Parametric Portfolio Associates held 80 shares of PAVmed worth $47K as of Q1 2022.
  • Parametric Portfolio Associates sold 115 PAVmed shares in Q1 2022, an estimated $85.5K.
  • PAVmed made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3637 holding.
  • Parametric Portfolio Associates first reported a position in PAVmed in Q2 2020 and has held it in 8 quarters since.
  • Parametric Portfolio Associates's PAVmed position peaked at $3.55M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.